In The Moment ... August 21, 2020 Show 886 Hour 1
SAB Biotherapeutics in Sioux Falls announced the first step in its trial of a COVID 19 therapeutic earlier this month, dosing the first group of healthy volunteers. Today, they're announcing the trial's next step.
Science and Technology reporting is brought to you by SDN Communications, your business broadband provider. Learn more at sdncommunications.com
